Sign in
4/A

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001387131-23-003381

Co-CEO & President bought 23,527,044 shares at $1.05 ($24,703,396)

From the SEC's structured data for this filing

Trades in this filing

Zanganeh Mahkam · Co-CEO & President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-08 Purchase : show line 1 in the form +16,778,415 $1.05 $17,617,336 24,573,798 I
2023-03-08 Purchase : show line 2 in the form +6,748,629 $1.05 $7,086,060 9,884,095 I
Open-market purchases · 23,527,044 sh · avg $1.05 · $24,703,396
Loading xslF345X03/zangeneh-form4a_030823.xml…